Alvotech (ALVO) Asset Utilization Ratio (2024 - 2026)
Alvotech's (ALVO) quarterly Asset Utilization Ratio came in at 0.23 in Q2 2026, down 9.53% on a YoY basis from 0.25 in Q2 2025, and down 13.44% quarter-over-quarter from 0.26 in Q1 2026.
Powered by 
Analysis
Alvotech (ALVO) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Asset Utilization Ratio for 3 consecutive years, with 0.23 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio fell 9.53% year-over-year to 0.23; the trailing twelve-month figure through Jun 2026 stood at 0.23 (down 9.53% YoY), and the FY2025 full-year result was 0.2, down 19.01% from the prior year.
- Asset Utilization Ratio retreated to 0.23 in Q2 2026 per ALVO's latest filing, from 0.26 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.31 in Q4 2025 and bottomed at 0.06 in Q1 2024.
- Historically, Asset Utilization Ratio has averaged 0.19 across 3 years, with a median of 0.22 in 2025.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio surged 290.06% in 2025, then declined 9.53% in 2026.
- Over 3 years, Asset Utilization Ratio stood at 0.16 in 2024, then jumped by 93.19% to 0.31 in 2025, then decreased by 25.25% to 0.23 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.23, 0.26, and 0.31 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 0.43 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.41 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 0.59 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 0.85 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 0.44 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 0.67 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 0.43 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 0.73 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.23 |
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | 0.31 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.16 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.06 |